STAT5B and chronic myelogenous leukemia, BCR-ABL1 positive: IST5-002 is a small molecule inhibitor that prevents both JAK2 and BCR-ABL-mediated phosphorylation of STAT5 and induces apoptosis in prostate cancer and chronic myeloid leukemia [82].